Page last updated: 2024-10-31

midazolam and Phobic Disorders

midazolam has been researched along with Phobic Disorders in 6 studies

Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.

Phobic Disorders: Anxiety disorders in which the essential feature is persistent and irrational fear of a specific object, activity, or situation that the individual feels compelled to avoid. The individual recognizes the fear as excessive or unreasonable.

Research Excerpts

ExcerptRelevanceReference
"Midazolam was often used as an adjunct therapy (42."1.48Immunizations under sedation at a paediatric hospital in Melbourne, Australia from 2012-2016. ( Cheng, DR; Elia, S; Perrett, KP, 2018)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (83.33)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cheng, DR1
Elia, S1
Perrett, KP1
Tschirch, FT2
Suter, K1
Froehlich, JM1
Studler, U1
Nidecker, A1
Eckhardt, B1
Beranek-Chiu, J1
Surber, C1
Weishaupt, D2
Wisłowska-Stanek, A1
Zienowicz, M1
Lehner, M1
Taracha, E1
Bidziński, A1
Maciejak, P1
Skórzewska, A1
Szyndler, J1
Płaźnik, A1
Göpfert, K1
Fröhlich, JM1
Brunner, G1
Bamgbade, OA1
Hollenhorst, J1
Münte, S1
Friedrich, L1
Heine, J1
Leuwer, M1
Becker, H1
Piepenbrock, S1

Reviews

1 review available for midazolam and Phobic Disorders

ArticleYear
Severe needle phobia in the perianesthesia setting.
    Journal of perianesthesia nursing : official journal of the American Society of PeriAnesthesia Nurses, 2007, Volume: 22, Issue:5

    Topics: Acute Disease; Adult; Ambulatory Surgical Procedures; Desensitization, Psychologic; Epilepsies, Part

2007

Trials

3 trials available for midazolam and Phobic Disorders

ArticleYear
Multicenter trial: comparison of two different formulations and application systems of low-dose nasal midazolam for routine magnetic resonance imaging of claustrophobic patients.
    Journal of magnetic resonance imaging : JMRI, 2008, Volume: 28, Issue:4

    Topics: Administration, Intranasal; Chi-Square Distribution; Feasibility Studies; Female; Humans; Hypnotics

2008
Low-dose intranasal versus oral midazolam for routine body MRI of claustrophobic patients.
    European radiology, 2007, Volume: 17, Issue:6

    Topics: Administration, Intranasal; Administration, Oral; Anxiety; Arousal; Chi-Square Distribution; Conscio

2007
Using intranasal midazolam spray to prevent claustrophobia induced by MR imaging.
    AJR. American journal of roentgenology, 2001, Volume: 176, Issue:4

    Topics: Administration, Intranasal; Adult; Arousal; Conscious Sedation; Double-Blind Method; Female; Humans;

2001

Other Studies

2 other studies available for midazolam and Phobic Disorders

ArticleYear
Immunizations under sedation at a paediatric hospital in Melbourne, Australia from 2012-2016.
    Vaccine, 2018, 06-14, Volume: 36, Issue:25

    Topics: Adolescent; Anesthetics, Inhalation; Australia; Child; Conscious Sedation; Female; Hospitals, Pediat

2018
Midazolam inhibits neophobia-induced Fos expression in the rat hippocampus.
    Journal of neural transmission (Vienna, Austria : 1996), 2006, Volume: 113, Issue:1

    Topics: Animals; Exploratory Behavior; Gene Expression Regulation; Hippocampus; Male; Midazolam; Phobic Diso

2006